Braidwell’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-34,094
| Closed | -$654K | – | 78 |
|
|
2024
Q4 | $654K | Buy |
+34,094
| New | +$654K | 0.02% | 73 |
|
|
2024
Q1 | – | Sell |
-323,102
| Closed | -$7.04M | – | 82 |
|
|
2023
Q4 | $7.04M | Sell |
323,102
-1,412,080
| -81% | -$30.8M | 0.26% | 66 |
|
|
2023
Q3 | $26.6M | Buy |
1,735,182
+528,882
| +44% | +$8.11M | 0.84% | 40 |
|
|
2023
Q2 | $28.7M | Buy |
+1,206,300
| New | +$28.7M | 0.94% | 38 |
|
|
2023
Q1 | – | Sell |
-313,403
| Closed | -$9.15M | – | 98 |
|
|
2022
Q4 | $9.15M | Buy |
+313,403
| New | +$9.15M | 0.31% | 73 |
|